Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent advances in basic science for overactive bladder.

Vivek Kumar1, Rebecca L Cross, Russell Chess-Williams

  • 1Department of Urology, Royal Hallamshire Hospital, Sheffield S10 2JF, UK. v.kumar@sheffield.ac.uk

Current Opinion in Urology
|June 2, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Are There Potential New Therapeutic Avenues for Treating Idiopathic Nocturia? ICI-RS 2025.

Neurourology and urodynamics·2025
Same author

A critical comparison of polypropylene and polyurethane sling materials after implantation in a suburethral sheep model.

Biomaterials·2025
Same author

What Is Required for AI to Improve the Assessment and Treatment of Patients With Lower Urinary Tract Dysfunction? ICI-RS 2025.

Neurourology and urodynamics·2025
Same author

From Clinical Trials to Routine Practice: Are Urodynamics Still Useful?

European urology·2025
Same author

Do We Need to Re-Focus on Functional Female Urethral Disorders in Lower Urinary Tract Dysfunction? ICI-RS 2024.

Neurourology and urodynamics·2024
Same author

Development of a Clinically Relevant Preclinical Animal Model to Mimic Suburethral Implantation of Support Materials for Stress Urinary Incontinence.

Neurourology and urodynamics·2024
Same journal

Role and relevance of genetic testing in patients with kidney stones: a review from EAU Section of Endourology.

Current opinion in urology·2026
Same journal

Advances in evaluating and delivering nontechnical skills training: The use of simulation, robotics, artificial intelligence and virtual reality.

Current opinion in urology·2026
Same journal

Educating for a sustainable future: faculty and student perspectives and a review of environmental sustainability in medical education - an EAU endourology study.

Current opinion in urology·2026
Same journal

Shaping the future of endourology: role of education, simulation and uro-technology: a scoping review by the EAU Section of Endourology.

Current opinion in urology·2026
Same journal

A review of emerging technologies and techniques for percutaneous nephrolithotomy access.

Current opinion in urology·2026
Same journal

Artificial intelligence in kidney cancer: a review of clinical applications across the disease spectrum.

Current opinion in urology·2026
See all related articles

Current overactive bladder treatments have limited efficacy. Research is exploring new drug targets beyond muscarinic receptors, focusing on the urothelium and neurotransmitters to improve bladder storage symptoms.

Area of Science:

  • Urology
  • Pharmacology
  • Neuroscience

Background:

  • Detrusor overactivity causes significant quality of life impairment.
  • Current treatments, primarily muscarinic receptor antagonists, have limited efficacy and side effects.

Purpose of the Study:

  • To review recent basic science developments for overactive bladder pathogenesis.
  • To identify novel pharmacological targets for improved overactive bladder management.

Main Methods:

  • Review of recent scientific literature on detrusor overactivity.
  • Analysis of emerging pathways and molecular targets.

Main Results:

  • The urothelium plays a crucial role in bladder storage, releasing neurotransmitters that affect sensory neurons.

Related Experiment Videos

  • Afferent stimulation involving the urothelium is increasingly recognized in overactive bladder pathophysiology.
  • No non-muscarinic agents have entered clinical practice yet.

    • Conclusions:

    • Future drug development for overactive bladder should consider novel pathways.
    • Targeting urothelial function and neurotransmitter release offers potential for improved therapies.